This research assesses how astaxanthin mitigates immunosuppression induced by lipopolysaccharide in macrophages, highlighting its therapeutic potential.
Key Points
Astaxanthin restores inflammatory responses in immunosuppressed macrophages, improving immune function.
Treatment with astaxanthin increased TNF-α and IL-6 production in LPS-stimulated macrophages, demonstrating its efficacy.
Transcriptomic analysis indicated that astaxanthin regulates multiple immune-related pathways, enhancing both innate and adaptive responses.
These findings suggest astaxanthin as a promising candidate for treating late-stage sepsis by addressing both hyperinflammation and immunosuppression.